Results 71 to 80 of about 38,243 (258)

Manifestaciones cutáneas de la hepatitis C

Medimay, 2010
El virus de la hepatitis C, es una causa muy importante de hepatitis tanto aguda como crónica y es un gran problema de salud, ya que puede evolucionar a la cirrosis y al carcinoma hepatocelular.
Doraiquis Lázara Acosta Medina, Israel Alfonso Trujillo, Maira Caridad Grillo Fernández, Gloria María Acosta Medina   +3 more
doaj   +4 more sources

Diagnóstico diferencial de virus hepatótropos y no hepatótropos en pacientes atendidos en el Laboratorio Regional de Referencia Virológica. Maracaibo-Venezuela, año 2007

Kasmera, 2010
: Viral hepatitis is a public health problem worldwide, caused by different etiologic agents, such as hepatitis A, B, C, D, E, F or G. However, cases have been reported related to liver disease caused by hepatotropic viruses, such as cytomegalovirus (CMV)
Costa-León Luciana, Monsalve-Castillo Francisca, Callejas-Valero Diana, Porto-Espinoza Leticia, Estévez, Jesús, Castellanos María Elena, Mindiola Raimy   +6 more
doaj  

Some considerations on the chronic viral hepatitis as a health problem

Medisan, 2021
Introduction: Nowadays, infectious diseases constitute one of the most frequent causes of death, with the result that current hepatitis epidemic is a health problem worldwide.
Yosvany Rojas Peláez, Yon Luis Trujillo Pérez, Ana Dianelis Reyes Escobar, Dayamí Bembibre Mozo   +3 more
doaj  

Harnessing Large‐Scale Multi‐Omics Data for Risk Prediction and Deep Phenotyping of Valvular Heart Diseases in the General Population

Advanced Science, EarlyView.
Large‐scale UK Biobank analyses identify clinical and proteomic signatures for early prediction of valvular heart disease and its subtypes. Proteins add predictive value for VHD, AVS, and MVR, with outcome‐specific compact panels showing translational potential. Multi‐layer evidence highlights matrix remodeling, protease regulation, immune inflammation,
Zhihao Jiang, Yang Liu, Mingyu Song, Ning Chen, Canqing Yu, Jun Lv, Eric Yuk Fai Wan, Lu Qi, Liming Li, Dianjianyi Sun, Bang Zheng   +10 more
wiley   +1 more source

NAFLD‐related hepatocellular carcinoma: The growing challenge

Hepatology, EarlyView., 2022
Risk and protective factors for NAFLD‐related hepatocellular carcinoma Abstract Hepatocellular carcinoma (HCC) is a common cause of cancer‐related mortality and morbidity worldwide. With the obesity pandemic, NAFLD‐related HCC is contributing to the burden of disease exponentially.
Pir Ahmad Shah, Rashmee Patil, Stephen A. Harrison   +2 more
wiley   +1 more source

Manifestaciones Extrahepáticas de la Infección por el Virus de la Hepatitis C

, 2009
Desde su identificación en 1989 el virus de la Hepatitis C ha sido muy estudiado, encontrando que además de su acción hepatotrópica presenta efectos extrahepáticos que tienen una relación directa a su gran afinidad linfotrópica que genera manifestaciones de naturaleza autoinmune ó de extensa estimulación inmunitaria que dan manifestaciones ...
García Ferrera, Waldo O., Nodarse Cuní, Hugo, Moredo Romo, Edelisa   +2 more
openaire   +2 more sources

Targeting p21‐High Senescent Kupffer Cells Nanotherapeutically Potentiates Antitumor Immunity in Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombus

Advanced Science, EarlyView.
Schematic illustration of a biomimetic SKEV@AAV platform targeting p21‐high senescent Kupffer cells (sKCs) in hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT). p21‐high sKCs accumulate in the PVTT microenvironment and establish an immunosuppressive, SASP‐rich environment that facilitates tumor cell proliferation and immune evasion.
Na Ta, Shuyi Wang, Boyan Zhang, Ning Liu, Yingchen Han, Aoran Liu, Ying Xu, Tingsong Chen, Ye Zhang, Qiuhua Luo, Tao Han   +10 more
wiley   +1 more source

Phase Ib study of anlotinib combined with TQB2450 in pretreated advanced biliary tract cancer and biomarker analysis

Hepatology, EarlyView., 2022
Phase 1b study of anlotinib combined with TQB2450 in pretreated advanced biliary tract cancer and biomarker analysis. Abstract Background and Aims We evaluated the efficacy and safety of the antiangiogenic tyrosine kinase inhibitor anlotinib plus TQB2450, a programmed death‐ligand 1 inhibitor in pretreated advanced biliary tract cancers (BTCs ...
Jun Zhou, Yongkun Sun, Wen Zhang, Jiajia Yuan, Zhi Peng, Wei Wang, Jifang Gong, Lin Yang, Yanshuo Cao, Hong Zhao, Chao Chen, Weifeng Wang, Lin Shen, Aiping Zhou   +13 more
wiley   +1 more source

Marcadores serológicos de hepatitis B y C, y VIH en La Calera y Cuambio, Guerrero, México Serological markers of hepatitis B and C, and HIV in La Calera and Cuambio, Guerrero, México

Salud Pública de México, 2011
OBJETIVO: Determinar la prevalencia de hepatitis B, C, y VIH en una muestra ampliada de dos de las comunidades rurales en las que se registró la mayor prevalencia de anticuerpos anti-core del virus de la hepatitis (anti-HBc) en la Encuesta Nacional de ...
Luis A Juárez-Figueroa, Felipe Javier Uribe-Salas, Carlos Jesús Conde-González, Miguel Ángel Sánchez-Alemán   +3 more
doaj  

Psychological Stress Associated Bile Acid Reprogramming Promotes Hepatocellular Carcinoma Progression

Advanced Science, EarlyView.
Depression is increasingly recognized as a risk factor for chronic diseases, yet its biological impact on cancer remains unclear. Using data from more than 490 000 participants across three international cohorts, we show that depression significantly increases the risk of liver cancer.
Ruijiang Zeng, Mengmeng Wang, Kang Wang, Zhuo Xing, Yulong Hong, Tongtong Li, Geng Zong, Chong Yang, Dan Zhang, Zhangling Chen, Xin Jin   +10 more
wiley   +1 more source